Market Cap
€21.99 Billion
EUR as of Jan. 1, 2026
US$25.82 Billion
| Company | Market Cap (USD) |
|---|---|
Thermo Fisher Scientific
|
$222.61 B |
Danaher
|
$164.98 B |
Siemens Healthineers AG
|
$57.84 B |
IDEXX Laboratories, Inc.
|
$53.62 B |
Lonza Group Ltd
|
$47.58 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$968.50 B |
Johnson & Johnson
|
$499.57 B |
AbbVie
|
$405.28 B |
Roche
|
$332.12 B |
UnitedHealth Group
|
$304.72 B |
Netherlands
languages
Healthcare
languages
Diagnostics & Research
Netherlands Healthcare
Netherlands Diagnostics & Research
Koninklijke Philips N.V. has the following listings and related stock indices.
Stock: Euronext: PHIA
Stock: BCBA: PHG
Stock: BMV: PHIAN
Stock: FSX: PHI1
Stock: MTA: PHIA
Stock: XETR: PHI1
Stock: XETR: PHIA
Stock: NYSE: PHG
Stock: FSX: PHIA
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.